| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/18/1998 | WO1998025971A1 Monovalent antibody fragments |
| 06/18/1998 | WO1998025960A1 Sequences derived from the genome of the c hepatitis virus, and use thereof |
| 06/18/1998 | WO1998025956A2 Human gtp-binding proteins |
| 06/18/1998 | WO1998025946A1 Monoclonal antibodies specific to endothelial cell cadherins and uses thereof |
| 06/18/1998 | WO1998025645A1 Therapeutic applications of antigens or epitopes associated with impaired cellular peptide processing, e.g. expressed on rma-s cells transfected with a b7-1 gene |
| 06/18/1998 | WO1998025641A1 MEDICAL USES OF scuPA/suPAR COMPLEX |
| 06/18/1998 | WO1998025574A2 Stimulation of an immune response to differentiation antigen stimulated by altered antigen |
| 06/18/1998 | WO1998018919A3 GABAa Receptor subunit epsilon-related protein |
| 06/18/1998 | WO1998017310A3 Polyanionic polymers as adjuvants for mucosal immunization |
| 06/18/1998 | WO1998013500A3 Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines |
| 06/18/1998 | DE19727813C1 Monoclonal antibody specific for CD164 |
| 06/18/1998 | DE19652586A1 Dhc-Peptid und Mittel Dhc-peptide and means |
| 06/18/1998 | CA2275340A1 Fusion protein comprising the whole or part of the pp65 protein of human cmv, useable in particular for preparing a vaccine |
| 06/18/1998 | CA2274900A1 Recombinant equine herpesvirus type 1 (ehv-1) comprising a dysfunctional gene 71 region and use thereof as a vaccine |
| 06/18/1998 | CA2274837A1 Therapeutic applications of antigens or epitopes associated with impaired cellular peptide processing, e.g. expressed on rma-s cells transfected with a b7-1 gene |
| 06/18/1998 | CA2274735A1 Human gtp-binding proteins |
| 06/18/1998 | CA2274728A1 Adipocyte-specific differentiation-related protein |
| 06/18/1998 | CA2274515A1 Glutathionylspermidine synthetase |
| 06/18/1998 | CA2274490A1 Non-m non-o hiv strains, fragments and applications |
| 06/18/1998 | CA2274477A1 Medical uses of scupa/supar complex |
| 06/18/1998 | CA2245956A1 Monoclonal antibodies specific to endothelial cell cadherins and uses thereof |
| 06/17/1998 | EP0848063A2 Nucleic acid constructs containing hybrid promotors for use in gene therapy |
| 06/17/1998 | EP0848011A1 Method of coupling polysaccharides to proteins |
| 06/17/1998 | EP0847402A1 Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor |
| 06/17/1998 | EP0847281A1 Method for detecting or monitoring the effectiveness of treatment of t cell mediated diseases |
| 06/17/1998 | EP0847280A2 Compositions and their uses |
| 06/17/1998 | EP0638175B1 In vitro test for helicobacter pylori |
| 06/17/1998 | EP0569537B1 Monoclonal antibodies to putative hcv envelope region and methods for using same |
| 06/17/1998 | CN1185176A DNA encoding human paplilloma virus type 18 |
| 06/17/1998 | CN1184817A Method for preparing active immunoglobulin used as oral liquor |
| 06/17/1998 | CN1184674A Pseudomonas active protein and method for producing same |
| 06/17/1998 | CN1038728C IBDV prodn. in continuous lines |
| 06/16/1998 | US5767285 Linkers useful for the synthesis of conjugates of methyltrithio antitumor agents |
| 06/16/1998 | US5767250 Complexes comprising truncated CMV gH polypeptides and escort proteins |
| 06/16/1998 | US5767248 Alzheimers |
| 06/16/1998 | US5767240 Activity-dependent neurotrophic factor |
| 06/16/1998 | US5767093 Glycoside antigen, inhibiting rejection of transplanted organs |
| 06/16/1998 | US5767075 Inhibiting protein interactions |
| 06/16/1998 | US5767063 Human IL-8 receptor and antibodies thereto |
| 06/16/1998 | US5766947 Useful in the diagnosis and therapy of a variety of immune-related diseases |
| 06/16/1998 | US5766946 Monoclonal antibodies to glycoprotein P |
| 06/16/1998 | US5766923 Isolated nucleic acid encoding ligands for FGFR |
| 06/16/1998 | US5766917 Method for identifying and producing a protease capable of cleaving the TNF receptor |
| 06/16/1998 | US5766906 Deletion mutation in 5'nontranslated region of viral genome |
| 06/16/1998 | US5766886 Modified antibody variable domains |
| 06/16/1998 | US5766882 recombinant poxviruses with foreign DNA in essential regions |
| 06/16/1998 | US5766878 Polynucleotides encoding a transcriptional response regulator of streptococcus pneumoniae |
| 06/16/1998 | US5766863 Kinase receptor activation assay |
| 06/16/1998 | US5766850 Human β2 integrin α subunit |
| 06/16/1998 | US5766845 Immunoreactive polypeptide compositions |
| 06/16/1998 | US5766844 Human T-cell line infected with HIV-2 which secretes functionally intact HIV-2 GP160. |
| 06/16/1998 | US5766838 Manual quantitating the number of leukocyte binding tissue cell over a defind are of tissue sample section |
| 06/16/1998 | US5766637 Microencapsulation process using supercritical fluids |
| 06/16/1998 | US5766633 Modified amino acid carrier, bioactive peptides |
| 06/16/1998 | US5766609 Administering to the animal to reduce protease activity of fleas feeding on said animal; antifertility agents; veterinary medicine |
| 06/16/1998 | US5766608 DNA molecules which encode the fimbrin protein of Haemophilus influenzae |
| 06/16/1998 | US5766607 Production of a vaccine against bovine keratoconjuctivitis |
| 06/16/1998 | US5766606 Genetic manipulation of gene encoding a group b streptococcus surface protein so that it is no longer able to bind to human iga |
| 06/16/1998 | US5766603 Producing live, attenuated hepatitis a vaccine by in vitro passage of virus in susceptible cell cultures without prior passage in subhuman primates |
| 06/16/1998 | US5766602 Recombinant packaging defective Sindbis virus vaccines |
| 06/16/1998 | US5766601 Cross-reactive influenza a immunization |
| 06/16/1998 | US5766600 Bactericide, viricide |
| 06/16/1998 | US5766599 Attenuated virus; genetic engineering |
| 06/16/1998 | US5766598 Immunology response to lentivirus gene |
| 06/16/1998 | US5766597 Vaccines providing immunity against plasmodium infections |
| 06/16/1998 | US5766594 Dna sequences encoding a polypeptide reactive with nti-mycoplasma gallisepticum chicken sera; expressed by a genetically engineered cell |
| 06/16/1998 | US5766593 Anti-inflammatory CD14 peptides |
| 06/16/1998 | US5766591 Methods and compositions useful for inhibition of angiogenesis |
| 06/16/1998 | US5766588 Tumor immunotherapy using anti-idiotypic antibodies |
| 06/16/1998 | US5766581 Increasing platelet number with polypeptide molecules attached to polyethylene glycol |
| 06/16/1998 | US5766571 Method of treating human breast cancer by administration of radiolabeled antibody and unsaturated fatty acids |
| 06/16/1998 | US5766570 Lymphocyte activation antigens and antibodies thereto |
| 06/16/1998 | US5766520 Preservation by foam formation |
| 06/16/1998 | CA2040374C Process for enhancing the resistance of aquatic animals to disease |
| 06/12/1998 | CA2192717A1 Method to increase and modify immune responses |
| 06/11/1998 | WO1998024912A2 Recombinant plague vaccine |
| 06/11/1998 | WO1998024911A2 Mutants of streptococcal toxin a and methods of use |
| 06/11/1998 | WO1998024910A2 Mutants of streptococcal toxin c and methods of use |
| 06/11/1998 | WO1998024906A2 Isolated mammalian monocyte cell genes; related reagents |
| 06/11/1998 | WO1998024900A1 Human g-protein receptor hcegh45, a pacap-like (g-protein pituitary adenylate cyclase activating polypeptide-like) receptor |
| 06/11/1998 | WO1998024898A2 Therapeutic composition comprising the kal protein and use of the kal protein |
| 06/11/1998 | WO1998024897A1 Junctional adhesion molecule (jam), a transmembrane protein of tight junctions |
| 06/11/1998 | WO1998024893A2 TRANSGENIC MAMMALS HAVING HUMAN IG LOCI INCLUDING PLURAL VH AND Vλ REGIONS AND ANTIBODIES PRODUCED THEREFROM |
| 06/11/1998 | WO1998024888A2 Polypeptides encoded by a human lipase-like gene, compositions and methods |
| 06/11/1998 | WO1998024887A2 Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof |
| 06/11/1998 | WO1998024884A1 Transgenic non-human animals capable of producing heterologous antibodies |
| 06/11/1998 | WO1998024882A1 Methods of preserving prokaryotic cells and compositions obtained thereby |
| 06/11/1998 | WO1998024482A2 Use of endothelin conjugates in therapy, new endothelin conjugates, substances containing them, and processes for producing them |
| 06/11/1998 | WO1998024478A2 Tumour therapy |
| 06/11/1998 | WO1998024475A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof |
| 06/11/1998 | WO1998024460A1 Extracts of salvia species having antiviral activity |
| 06/11/1998 | WO1998024327A1 High moisture nutrient formulation for poultry |
| 06/11/1998 | WO1998024319A1 Novel saponin compositions and uses thereof |
| 06/11/1998 | WO1998012910A3 Novel CREBa isoform |
| 06/11/1998 | CA2722378A1 Human antibodies that bind tnf alpha |
| 06/11/1998 | CA2274316A1 Therapeutic composition comprising the kal protein and use of the kal protein for the treatment of retinal, renal, neuronal and neural injury |
| 06/11/1998 | CA2274105A1 Transgenic non-human animals capable of producing heterologous antibodies |
| 06/11/1998 | CA2274084A1 A nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals |
| 06/11/1998 | CA2273822A1 Mutants of streptococcal toxin a and methods of use |
| 06/11/1998 | CA2273218A1 Tumour therapy |